Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 1.1B | 1.1B | 1.0B | 929.2M |
| Cost of revenue | 165.0M | 160.6M | 170.5M | 138.1M |
| Gross profit | 952.3M | 967.3M | 831.1M | 791.0M |
| Operating expense | ||||
| Research & development | 481.9M | 542.0M | 496.2M | 454.5M |
| Selling general and admin | 459.3M | 504.7M | 455.2M | 443.7M |
| Other operating expenses | — | — | — | — |
| Operating income | 11.1M | -79.4M | -120.3M | -107.2M |
| Non operating interest income | ||||
| Income | 5.8M | 7.8M | 10.6M | 13.2M |
| Expense | — | — | — | — |
| Other income expense | 4.0M | -13.7M | 11.3M | -12.0M |
| Pretax income | 20.9M | -85.4M | -98.3M | -105.9M |
| Tax provision | 19.6M | 66.5M | 23.0M | 14.5M |
| Net income | 1.3M | -151.9M | -121.4M | -120.4M |
| Basic EPS | 0 | -1.4 | -1.2 | -1.2 |
| Diluted EPS | 0 | -1.4 | -1.2 | -1.2 |
| Basic average shares | 106.9M | 106.3M | 105.9M | 104.7M |
| Diluted average shares | 111.2M | 106.3M | 105.9M | 104.7M |
| EBITDA | 43.9M | -29.2M | -49.0M | -82.2M |
| Net income from continuing op. | 1.3M | -151.9M | -121.4M | -120.4M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |